Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterations

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Tuch, Brian B ^a   Laborde, Rebecca R ^b   Xu, Xing ^a   Gu, Jian ^c   Chung, Christina B ^a   Monighetti, Cinna K ^a   Stanley, Sarah J ^a   Olsen, Kerry D ^b   Kasperbauer, Jan L ^b   Moore, Eric J ^b   Broomer, Adam J ^a   Tan, Ruoying ^a   Brzoska, Pius M ^a   Muller, Matthew W ^a   Siddiqui, Asim S ^a   Asmann, Yan W ^b   Sun, Yongming ^a   Kuersten, Scott ^c   Barker, Melissa A ^a   De La Vega, Francisco M ^a   Smith, David I ^b   more..

^a Life Technologies Corporation   (United States)

^b MAYO CLINIC   (United States)

^c Life Technologies Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ACCURACY; ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE DELETION; GENE DUPLICATION; GENE EXPRESSION; GENE MUTATION; GENE NUMBER; GENOME; HUMAN; HUMAN TISSUE; MOUTH CARCINOMA; NUCLEOTIDE SEQUENCE; ORAL SQUAMOUS CELL CARCINOMA; RNA SEQUENCE; SQUAMOUS CELL CARCINOMA; ALLELIC IMBALANCE; CLUSTER ANALYSIS; DNA MICROARRAY; DNA SEQUENCE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETICS; METHODOLOGY; MOUTH TUMOR; MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELIC IMBALANCE; CARCINOMA, SQUAMOUS CELL; CLUSTER ANALYSIS; GENE DELETION; GENE DOSAGE; GENE DUPLICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MOUTH NEOPLASMS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 77949536719     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009317     Document Type: Article

References (73)

1. Wang Z, Gerstein M, Snyder M (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10: 57-63.
2. Bentley DR (2006) Whole-genome re-sequencing. Curr Opin Genet Dev 16: 545-552.
3. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621-628.
4. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, et al. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456: 470-476.
5. Kim J, Bartel DP (2009) Allelic imbalance sequencing reveals that single-nucleotide polymorphisms frequently alter microRNA-directed repression. Nat Biotechnol 27: 472-477.
6. Campbell PJ, Stephens PJ, Pleasance ED, O'Meara S, Li H, et al. (2008) Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet 40: 722-729.
7. Stratton MR, Campbell PJ, Futreal PA (2009) The cancer genome. Nature 458: 719-724.
8. Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, et al. (2008) DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456: 66-72.
9. Thomas RK, Nickerson E, Simons JF, Janne PA, Tengs T, et al. (2006) Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing. Nat Med 12: 852-855.
10. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
11. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin.
12. Leethanakul C, Patel V, Gillespie J, Pallente M, Ensley JF, et al. (2000) Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene 19: 3220-3224.
13. Alevizos I, Mahadevappa M, Zhang X, Ohyama H, Kohno Y, et al. (2001) Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene 20: 6196-6204.
14. Belbin TJ, Singh B, Barber I, Socci N, Wenig B, et al. (2002) Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res 62: 1184-1190.
15. Al Moustafa AE, Alaoui-Jamali MA, Batist G, Hernandez-Perez M, Serruya C, et al. (2002) Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 21: 2634-2640.
16. Yu YH, Kuo HK, Chang KW (2008) The evolving transcriptome of head and neck squamous cell carcinoma: a systematic review. PLoS ONE 3: e3215.
17. Hosokawa Y, Arnold A (1998) Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression. Genes Chromosomes Cancer 22: 66-71.
18. LaFramboise T, Weir BA, Zhao X, Beroukhim R, Li C, et al. (2005) Allele-specific amplification in cancer revealed by SNP array analysis. PLoS Comput Biol 1: e65.
19. Herrick J, Conti C, Teissier S, Thierry F, Couturier J, et al. (2005) Genomic organization of amplified MYC genes suggests distinct mechanisms of amplification in tumorigenesis. Cancer Res 65: 1174-1179.
20. Marioni JC, Mason CE, Mane SM, Stephens M, Gilad Y (2008) RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res 18: 1509-1517.
21. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174.
22. Lopez P, Vidal F, Rassoulzadegan M, Cuzin F (1999) A role of inhibin as a tumor suppressor in Sertoli cells: down-regulation upon aging and repression by a viral oncogene. Oncogene 18: 7303-7309.
23. Yoshinaga K, Yamashita K, Mimori K, Tanaka F, Inoue H, et al. (2008) Activin a causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells. Ann Surg Oncol 15: 96-103.
24. Lee YS, Dutta A (2007) The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21: 1025-1030.
25. Mayr C, Hemann MT, Bartel DP (2007) Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315: 1576-1579.
26. Miyazawa J, Mitoro A, Kawashiri S, Chada KK, Imai K (2004) Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity. Cancer Res 64: 2024-2029.
27. Adachi N, Lieber MR (2002) Bidirectional gene organization: a common architectural feature of the human genome. Cell 109: 807-809.
28. Trinklein ND, Aldred SF, Hartman SJ, Schroeder DI, Otillar RP, et al. (2004) An abundance of bidirectional promoters in the human genome. Genome Res 14: 62-66.
29. Beissbarth T, Speed TP (2004) GOstat: find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics 20: 1464-1465.
30. Liotta LA (1986) Tumor invasion and metastases-role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res 46: 1-7.
31. Johnsen M, Lund LR, Romer J, Almholt K, Dano K (1998) Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol 10: 667-671.
32. Kang CJ, Chen YJ, Liao CT, Wang HM, Chang JT, et al. (2009) Transcriptome profiling and network pathway analysis of genes associated with invasive phenotype in oral cancer. Cancer Lett 284: 131-140.
33. Tsui IF, Poh CF, Garnis C, Rosin MP, Zhang L, et al. (2009) Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasias. Int J Cancer 125: 2219-2228.
34. Chen CH, Chien CY, Huang CC, Hwang CF, Chuang HC, et al. (2009) Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity. Oncogene 28: 2723-2737.
35. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, et al. (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29: 308-311.
36. (2010) NextBio Professional System. https://www.nextbio.com/.
37. Xu L, Shen SS, Hoshida Y, Subramanian A, Ross K, et al. (2008) Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases. Mol Cancer Res 6: 760-769.
38. Bohen SP, Troyanskaya OG, Alter O, Warnke R, Botstein D, et al. (2003) Variation in gene expression patterns in follicular lymphoma and the response to rituximab. Proc Natl Acad Sci U S A 100: 1926-1930.
39. Wachi S, Yoneda K, Wu R (2005) Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics 21: 4205-4208.
40. Dehan E, Ben-Dor A, Liao W, Lipson D, Frimer H, et al. (2007) Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung Cancer 56: 175-184.
41. Feinberg AP (1999) Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: an introduction. Cancer Res 59: 1743s-1746s.
42. Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, et al. (2003) Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299: 1753-1755.
43. Gabory A, Ripoche MA, Yoshimizu T, Dandolo L (2006) The H19 gene: regulation and function of a non-coding RNA. Cytogenet Genome Res 113: 188-193.
44. Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, et al. (2007) The H19 non-coding RNA is essential for human tumor growth. PLoS ONE 2: e845.
45. Zhang Y, Tycko B (1992) Monoallelic expression of the human H19 gene. Nat Genet 1: 40-44.
46. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, et al. (1993) Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362: 749-751.
47. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, et al. (1993) Relaxation of imprinted genes in human cancer. Nature 362: 747-749.
48. Feinberg AP, Tycko B (2004) The history of cancer epigenetics. Nat Rev Cancer 4: 143-153.
49. Holm TM, Jackson-Grusby L, Brambrink T, Yamada Y, Rideout WM, 3rd, et al. (2005) Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 8: 275-285.
50. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, et al. (2004) Large-scale copy number polymorphism in the human genome. Science 305: 525-528.
51. Perry GH, Tchinda J, McGrath SD, Zhang J, Picker SR, et al. (2006) Hotspots for copy number variation in chimpanzees and humans. Proc Natl Acad Sci US A 103: 8006-8011.
52. Henrichsen CN, Vinckenbosch N, Zollner S, Chaignat E, Pradervand S, et al. (2009) Segmental copy number variation shapes tissue transcriptomes. Nat Genet 41: 424-429.
53. Cahan P, Li Y, Izumi M, Graubert TA (2009) The impact of copy number variation on local gene expression in mouse hematopoietic stem and progenitor cells. Nat Genet 41: 430-437.
54. Lee JA, Lupski JR (2006) Genomic rearrangements and gene copy-number alterations as a cause of nervous system disorders. Neuron 52: 103-121.
55. McCarroll SA, Altshuler DM (2007) Copy-number variation and association studies of human disease. Nat Genet 39: S37-42.
56. Chiang DY, Getz G, Jaffe DB, O'Kelly MJ, Zhao X, et al. (2009) High-resolution mapping of copy-number alterations with massively parallel sequencing. Nat Methods 6: 99-103.
57. Freier K, Sticht C, Hofele C, Flechtenmacher C, Stange D, et al. (2006) Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma. Genes Chromosomes Cancer 45: 118-125.
58. Kim JK, Diehl JA (2009) Nuclear cyclin D1: an oncogenic driver in human cancer. J Cell Physiol 220: 292-296.
59. Schuuring E (1995) The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes - a review. Gene 159: 83-96.
60. Du Y, Weed SA, Xiong WC, Marshall TD, Parsons JT (1998) Identification of a novel cortactin SH3 domain-binding protein and its localization to growth cones of cultured neurons. Mol Cell Biol 18: 5838-5851.
61. Ortega S, Malumbres M, Barbacid M (2002) Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 1602: 73-87.
62. Krimpenfort P, Ijpenberg A, Song JY, van der Valk M, Nawijn M, et al. (2007) p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Nature 448: 943-946.
63. Gil J, Peters G (2006) Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 7: 667-677.
64. Nusse R (2005) Wnt signaling in disease and in development. Cell Res 15: 28-32.
65. Willert K, Jones KA (2006) Wnt signaling: is the party in the nucleus? Genes Dev 20: 1394-1404.
66. Clement G, Guilleret I, He B, Yagui-Beltran A, Lin YC, et al. (2008) Epigenetic alteration of the Wnt inhibitory factor-1 promoter occurs early in the carcinogenesis of Barrett's esophagus. Cancer Sci 99: 46-53.
67. Wissmann C, Wild PJ, Kaiser S, Roepcke S, Stoehr R, et al. (2003) WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol 201: 204-212.
68. Ghaemmaghami S, Huh WK, Bower K, Howson RW, Belle A, et al. (2003) Global analysis of protein expression in yeast. Nature 425: 737-741.
69. Sasaki H, Matsui Y (2008) Epigenetic events in mammalian germ-cell development: reprogramming and beyond. Nat Rev Genet 9: 129-140.
70. Tsafrir D, Bacolod M, Selvanayagam Z, Tsafrir I, Shia J, et al. (2006) Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res 66: 2129-2137.
71. Haverty PM, Fridlyand J, Li L, Getz G, Beroukhim R, et al. (2008) High-resolution genomic and expression analyses of copy number alterations in breast tumors. Genes Chromosomes Cancer 47: 530-542.
72. Tang F, Barbacioru C, Wang Y, Nordman E, Lee C, et al. (2009) mRNA-Seq whole-transcriptome analysis of a single cell. Nat Methods 6: 377-382.
73. Lipson D, Ben-Dor A, Dehan E, Yakhini Z (2004) Joint Analysis of DNA Copy Numbers and Gene Expression Levels. Algorithms Bioinformatics. Bergen, Norway: Springer. pp 135-146.